Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 4 May 23 EFFECT Notice of effectiveness
- 23 Feb 23 POS AM Prospectus update (post-effective amendment)
- 23 Feb 23 POSASR Automatic shelf registration (post-effective amendment)
-
10 Nov 21 S-3ASR Automatic shelf registration
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
C4 Therapeutics, Inc.
We consent to the use of our report dated March 11, 2021, with respect to the consolidated financial statements of C4 Therapeutics, Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
November 10, 2021